Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

Venetoclax and Selinexor in Treating Patients With Relapsed or Refractory High Risk Hematologic Malignancies

Venetoclax and Selinexor in Treating Patients With Relapsed or Refractory High Risk Hematologic Malignancies

Conditions:   Diffuse Large B-cell Lymphoma;   Acute Myeloid Leukemia;   Non-Hodgkin’s Lymphoma
Interventions:   Drug: Venetoclax;   Drug: Selinexor
Sponsors:   Michael Byrne;   Karyopharm Therapeutics Inc;   AbbVie
Not yet recruiting
ClinicalTrials.gov: Hematology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 21, 2019 / by / in
Comments